+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Regeneus Ltd - logo

Founded in 2007, Regeneus are a Sydney-based regenerative medicine company developing a portfolio of innovative cell-based therapies, with a focus on osteoarthritis and musculoskeletal disorders, as well as oncology and dermatology diseases. The company's portfolio of therapeutic products is being developed using stem cell and immune oncology technology platforms.The company has two product candidates in Phase 1 trials for humans, Progenza and RGSH4K. Regeneus is headquartered in New South Wales, Australia.

Osteoarthritis - Pipeline Review, H2 2020 - Product Thumbnail Image

Osteoarthritis - Pipeline Review, H2 2020

  • Drug Pipelines
  • August 2020
  • 384 Pages
  • Global
From
Veterinary Oncology - Global Strategic Business Report - Product Thumbnail Image

Veterinary Oncology - Global Strategic Business Report

  • Report
  • November 2024
  • 93 Pages
  • Global
From
Canine Stem Cell Therapy - Global Strategic Business Report - Product Thumbnail Image

Canine Stem Cell Therapy - Global Strategic Business Report

  • Report
  • November 2024
  • 197 Pages
  • Global
From
From
Autologous Cell Therapies - Global Strategic Business Report - Product Thumbnail Image

Autologous Cell Therapies - Global Strategic Business Report

  • Report
  • November 2024
  • 194 Pages
  • Global
From
From
From
Pet Cancer Therapeutics Global Market Report 2024 - Product Thumbnail Image

Pet Cancer Therapeutics Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
From
From
Veterinary Oncology Global Market Report 2024 - Product Thumbnail Image

Veterinary Oncology Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Companion Animal Arthritis Global Market Report 2024 - Product Thumbnail Image

Companion Animal Arthritis Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
From
Loading Indicator